Strategic Audit Report Pfizer – Brand-Name Pharmaceutical Manufacturing (U.S.)

Authors

Madeleine Grimm, University of Nebraska - LincolnFollow
Meghan Schuette, University of Nebraska - LincolnFollow
Trent Lockard, University of Nebraska - LincolnFollow
Connor Boudreau, University of Nebraska - LincolnFollow
Kollin Goff, University of Nebraska-LincolnFollow

Document Type

Thesis

Date of this Version

Spring 5-3-2023

Citation

Boudreau, C., Goff, K., Grimm, M., Lockard, T., & Schuette, M. (2023). Strategic Audit Report Pfizer – Brand-Name Pharmaceutical Manufacturing (U.S.). Undergraduate Honors Thesis. University of Nebraska-Lincoln.

Comments

Copyright Connor Boudreau, Kollin Goff, Madeleine Grimm, Trent Lockard, Meghan Schuette 2023.

Abstract

The purpose of this strategic audit report is to provide an in-depth analysis of different aspects of Pfizer Inc.’s business operations and an overview of the different types of strategies that Pfizer employs within the Brand-Name Pharmaceutical Manufacturing Industry. The audit contains analyses of the company’s history and strategic leadership strategies, external environment, internal environment, performance, and competitive dynamics. These aspects are examined to provide a foundation for further analysis of Pfizer’s strategies in the context of the environment. This report also analyzes the company’s business and corporate-level strategies, the impact of recent mergers and acquisitions, corporate governance practices, and organizational structures and controls. Through these analyses, we concluded that Pfizer’s recent strategic decisions have been good choices for the company’s future plans.